Literature DB >> 10227787

A new device for selective removal of CD4+ T cells.

H Onodera, Y Abe, M Yoshida, N Yamawaki, Y Yamashita, H Matsuo, K Ichinose, I Otsuru, N Shibuya.   

Abstract

To control antigen (Ag)-specific immune cells is important in the treatment of autoimmune diseases. In particular, a direct solution may be obtained by controlling the CD4+ cell function that controls the immune response of autoimmune T cells. Thus, a technique to selectively remove CD4+ cells has been developed, based on the consideration that the immune system may possibly be modified by selectively removing the CD4+ cells by means of extracorporeal circulation. The currently developed device to selectively remove CD4+ cells uses a material made of nonwoven fabric with monoclonal antibodies immobilized on the surface. With this device, removal of only CD4+ cells from human mononuclear cells suspension can be accomplished. Moreover, CD4+ cells can be specifically removed from peripheral whole blood by direct perfusion. This review outlines a series of procedures for selective cell removal and the results of our research.

Entities:  

Mesh:

Year:  1998        PMID: 10227787     DOI: 10.1111/j.1744-9987.1998.tb00071.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN: 1091-6660


  1 in total

1.  Exploring the feasibility of selective depletion of T lymphocyte subsets by whole blood immunoadsorption cytapheresis.

Authors:  M Belak; C R Valeri; D G Wright
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.